The randomized controlled trial in studies using biomarkers.
The randomized controlled trial (RCT) is a scientific experiment during which observations on the effects of therapy or a preventive action are conducted by the researcher under rigorous control. The purpose of the experiment is to clear the uncertainties surrounding a clinical/research issue and involves isolating the 'treatment' and 'end result' variables from external influences. RCTs therefore make use of scientific method standards: measuring, which includes the possibility of reproducing observations; controlling factors unconnected to the cause-effect relationship of interest; and the external verification or 'falsification' of the cause-effect relationship. Many RCTs are now including biomarkers to answer scientific questions in a more accurate way. In the present methodological paper, the main aspects involved in the design and conduction of a trial are discussed, with special emphasis on the use of biomarkers. Aspects that are often overlooked by scientists involved in the design of trials include multiple comparisons, subgroup analysis, the duration of the observations, the use of surrogate endpoints, and ethical issues. This review summarizes the main issues that should be addressed in a protocol, and illustrates these with an example.
Vineis
Paolo
P
Dipartimento di Scienze Biomediche e Oncologia Umana, via Santena 7, University of Torino, Torino, Italy. paolo.vineis@unito.it
D015415:Biomarkers; D004249:DNA Damage; D005419:Flavonoids / Q000494:pharmacology; D006801:Humans; D016032:Randomized Controlled Trials as Topic / Q000941:ethics; D012107:Research Design
D015415:Biomarkers; D005419:Flavonoids